Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical and Diagnostic industry, based in Norway.

Description

Curida is specialized in development activities and full-scale commercial manufacturing of aseptic, sterile and non-sterile fill & finish. We have core competence in manufacturing of liquid pharmaceuticals: Blow-Fill-Seal (BFS) and Nasal Sprays. Curida also has a Bio-CDMO unit with GMP ready manufacturing facilities for monoclonal antibodies, serving the IVD industry and Pre-clinical stage companies

Type of Drugs Manufactured:

Small Molecule;Biologics;Medical Devices

CDMO Services:

Aseptic Fill Finish;Research & Development;Clinical Trials materials and logistics;Analytical Development

No. of Manufacturing Facilities:

3-5

High Potent Products capabilities:

OEB 3;OEB 4-5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

EMA (Europe);ISO;GMP;NMPA (China);Health Canada

Manufacturing Technologies:

Blow-Fill-Seal (BFS);Inhalers;Liquids

Current Capacity:

Curida has available capacity in BFS ampoules and Nasal Sprays due to the recent investments made to increase our capacities.

Contact Information

Website
Phone
Address
Fornebu , Martin Linges vei 25, 1364, Norway
Zip/Post Code
1364

AI and Digital Manufacturing Benchmarking Survey

Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.